The WEAR ETF Snapshot

Data as of: 6/22/2018

ETF Info
Ticker WEAR
Expense Ratio 0.85%
Index Provider EQM Indexes LLC
Exchange NYSE
CUSIP 30151e707
Shares Outstanding 100,001
Number of Holdings 59

The Fund and the Index

The Fund will normally invest at least 80% of its total assets in securities of the Index.  The Index is designed to track the performance of companies that have a current or future business focus on wearable technology devices and/or components of such devices, as determined by EQM Indexes LLC (the “Index Provider”).

Top 10 Holdings

Name Shares Market Value % of Market Value % of Net Assets
SAMSUNG ELECTRONICS CO LTD 559 $21,601.43 71.21% 71.21%
Omron Corp 500 $27,564.44 7.18% 7.18%
SEIKO EPSON CORP 3000 $63,320.95 15.29% 15.29%
GN STORE NORD A/S 1383 $37,747.56 1.09% 1.09%
GOPRO INC-CLASS A 9304 $66,908.75 0.17% 0.17%
BOSTON SCIENTIFIC CORP 1776 $46,021.97 0.16% 0.16%
DEXCOM INC 583 $34,602.43 0.16% 0.16%
FITBIT INC - A 8567 $56,781.99 0.16% 0.16%
AXON ENTERPRISE INC 808 $20,315.02 0.15% 0.15%
BIOTELEMETRY INC 1243 $37,873.54 0.15% 0.15%

ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities.

Month End Performance as of: 5/31/2018

1 Mo. 3 Mo. YTD 1 Year Since Inception
Fund NAV 9.22% 9.82% 13.96% 22.55% 37.82%
Closing Price 9.20% 10.19% 13.33% 24.44% 40.61%

Quarter End Performance as of: 3/31/2018

1 Mo. 3 Mo. YTD 1 Year Since Inception
Fund NAV -0.60% 3.15% 3.15% 13.76% 24.75%
Closing Price -1.60% 1.21% 1.21% 13.82% 25.57%

The performance data quoted represents past performance. Past performance does not guarantee future results. Current performance may be lower or higher than the performance data quoted. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost. Returns less than one year are not annualized. You cannot invest directly in an index. As stated in the prospectus, the total annual operating expenses are 0.85%. Shares are bought and sold at market price (closing price) not net asset value (NAV) and are not individually redeemed from the Fund. Market performance is determined using the bid/ask midpoint at 4:00pm Eastern time when the NAV is typically calculated. Brokerage commissions will reduce returns.

Index Information

Companies eligible for inclusion in the Index include companies that derive a portion of their revenues from (1) the sale of technology devices that can be worn on the body, either as an accessory or as part of clothing, and are used for applications such as sports and wellness, industrial and military, infotainment/lifestyle, or healthcare and medical (“Wearable Devices”); or (2) the manufacture of components used in Wearable Devices, such as semiconductors, sensors, and displays (“Wearable Components”)   Wearable Technology Companies Index constituents are categorized as “core” holdings, meaning securities of Wearable Technology Companies that derive significant revenues, as defined by the Index Provider, from the sale of Wearable Devices, and “non-core” holdings, meaning securities of Wearable Technology Companies that derive minimal revenue, as defined by the Index Provider, from the sale of Wearable Devices and/or the manufacture of Wearable Components. Index weightings are determined according to a modified equal weighting methodology: at each rebalance of the Index, constituents are equal-weighted, but core holdings are subject to a multiplier of 1.5 times the equal weight.  Non-core holdings are then equal-weighted.  The Index is rebalanced semi-annually but may be rebalanced more frequently for specific corporate events, as determined by the Index Provider.  The Index is unmanaged and cannot be invested in directly.

Carefully consider the Fund’s investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Fund’s prospectus and Summary Prospectus, which may be obtained by visiting . Read the prospectus and Summary Prospectus  carefully before investing.